Improved Breast MRI With SWIFT

Completed · Not applicable

Conditions studied: Breast Cancer

In brief

Today's medical imaging methods have insufficient specificity for reliable differentiation between benign and malignant breast lesions in patients. Pathologic evaluation is currently the only way to obtain a definitive diagnosis. This research will use a novel method of magnetic resonance imaging (MRI), Sweep Imaging with Fourier Transform (SWIFT), at a very high magnetic field (4 Tesla) to distinguish malignant from benign breast lesions. This research will reveal whether the SWIFT sequence bears new capabilities in medical imaging for breast cancer diagnosis.

Key facts

Study ID

NCT01156987

Run by

University of Minnesota

People needed

31

Starts

2009-08-01

Expected to finish

2015-08-01

Last updated by the study team

2017-03-09

Who can join

Age: 18 and older, up to 80. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women with a clinically or mammographically identified suspicious breast mass that is likely to be biopsied or surgically removed.

You may not qualify if…

• Pregnancy
• Ferromagnetic implants
• History of shotgun wounds and shrapnel
• Obesity (>250 pounds)
• Cardiac pacemaker
• Incompatible implanted medical device
• Severe claustrophobia
• Major surgeries with potential of ferromagnetic implants
• Severe asthma and allergies
• i-STAT system, a handheld blood analyzer (I-STAT) creatinine test, estimated glomerular filtration rate (GFR) <30
• Metallic object (greater than 2 cm in length) in the breast
• Metallic ink tatoo within 20 cm of the breast (approximately 8 inches)

Where it is running

• Center for Magnetic Resonance Research — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.